Jagsonpal Pharmaceuticals Limited

NSE:JAGSNPHARM.NS

268.1 (INR) • At close August 7, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2026 Q12025 Q42025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q2
Revenue 756.12585.6740.25746.92614.39434.86472.34578.29601.53554.541601.398605.262605.969521.355544.739594.887599.986427.665571.043563.527316.521295.175420.104418.059452.34384.022418.945441.249424.04326.731380.565289.068268.965293.589343.824400.19402.417392.033346.107332.78369.885388.486324.286329.606339.131312.808377.016367.897380.788381.331493.212417.833372.269414.619465.967476.549
Cost of Revenue 269.27217.2265.17475.02405.4317.87197.41209.09222.89234.033228.4209.376255.259242.937217.337235.082265.701152.055252.878278.944125.46378.68139.854158.87184.907139.557179.664196.571213.529112.691203.08155.124140.20686.893171.186168.772162.646142.861126.424128.497193.451228.171156.942148.112153.60967.344189.614178.484211.618214.702264.682207.829174.409191.384220.679228.948
Gross Profit 486.85368.4475.08271.9208.99116.99274.93369.2378.64320.508372.998395.886350.71278.418327.402359.805334.285275.61318.165284.583191.058216.495280.25259.189267.433244.465239.281244.678210.511214.04177.485133.944128.759206.696172.638231.418239.771249.172219.683204.283176.434160.315167.344181.494185.522245.464187.402189.413169.17166.629228.53210.004197.86223.235245.288247.601
Gross Profit Ratio 0.6440.6290.6420.3640.340.2690.5820.6380.6290.5780.620.6540.5790.5340.6010.6050.5570.6440.5570.5050.6040.7330.6670.620.5910.6370.5710.5550.4960.6550.4660.4630.4790.7040.5020.5780.5960.6360.6350.6140.4770.4130.5160.5510.5470.7850.4970.5150.4440.4370.4630.5030.5310.5380.5260.52
Reseach & Development Expenses 000000000000000003.4580001.5410001.2090003.7430005.6440004.6880003.2850005.5480006.933000000
General & Administrative Expenses 000000000-50.923000165.93500018.8000122.09000000000000000000000000.4520000.4000000
Selling & Marketing Expenses 000000000154.65000102.1900096.222000162.940000000000000000000000038.54700038.262000000
SG&A 0165.680132.46117.3394.3398.03126.7179.04103.727104.868117.015148.815268.125151.319140.8297.674115.022153.32156.58118.198285.03146.164124.69131.451122.424127.404126.476106.242123.473104.214110.49795.866114.81196.787101.144111.611125.86992.17496.74682.3694.79574.4875.4689.5328.81891.35497.29887.489333.71398.2296.3730000
Other Expenses 368.250340.8700025.2122.7419.9728.1517.40911.2073.135-28.82619.5362.8498.218-13.7385.3484.1357.845203.6926.5084.4386.712-4.1742.786220.580.879225.199198.1450.001169.1031.187166.024216.418222.267209.136202.697186.24157.776150.427155.8150.001163.363214.62164.84177.271155.5862.912199.817189.968184.7763.214203.233204.538
Operating Expenses 368.25165.68340.87132.46117.3394.33245.09290.1296.2270.995289.96268.899288.461273.723274.99259.273244.374219.144256.081238.987167.341203.692257.205236.783247.922211.838219.582220.58200.591225.199198.145171.477169.103204.567166.024216.418222.267209.136202.697186.24157.776150.427155.815163.769163.363214.62164.84177.271155.586154.995199.817189.968184.776195.708203.233204.538
Operating Income 118.6202.72134.21139.4491.6622.6655.05101.8482.4477.634100.447138.19462.249-2.98552.412100.53289.91156.46662.08445.59623.71712.80323.04522.40619.51132.62719.69924.0989.92-11.159-22.926-39.44842.2070.974128.6836.2938.01723.5884.8645.9756.325-0.6810.3286.97110.09812.52811.740.9590.086-2.08915.547.4941.50612.69731.74632.701
Operating Income Ratio 0.1570.3460.1810.1870.1490.0520.1170.1760.1370.140.1670.2280.103-0.0060.0960.1690.150.1320.1090.0810.0750.0430.0550.0540.0430.0850.0470.0550.023-0.034-0.06-0.1360.1570.0030.3740.0160.020.060.0140.0180.017-0.0020.0010.0210.030.040.0310.0030-0.0050.0320.0180.0040.0310.0680.069
Total Other Income Expenses Net 25.7122.99252.5114.25-20.5622.722.9520.5318.47-4.422-1.771-0.259-55.046-9.46418.9552.2157.16417.3653.9922.9676.5362.3955.4962.9575.5354.7431.744-0.144-0.829-0.528-1.960.001-0.648-1.091122.072-8.701-9.484-16.442-12.122-11.727-12.043-10.991-11.162-10.551-11.752-17.828-10.822-11.183-13.498-10.888-13.173-12.54203.21400
Income Before Tax 144.3187.08386.72153.6971.145.3652.7999.63100.9173.21298.676137.9357.2032.00271.367102.74797.07573.83166.07648.56330.25315.19828.54125.36325.04637.3721.44322.1249.091-11.687-22.926-39.447-42.2070.974128.6836.2938.01723.5884.8645.9756.325-0.6810.3286.97210.09812.52811.740.9590.0860.82315.547.4941.50615.91131.74632.701
Income Before Tax Ratio 0.1910.1490.5220.2060.1160.1040.1120.1720.1680.1320.1640.2280.0120.0040.1310.1730.1620.1730.1160.0860.0960.0510.0680.0610.0550.0970.0510.050.021-0.036-0.06-0.136-0.1570.0030.3740.0160.020.060.0140.0180.017-0.0020.0010.0210.030.040.0310.00300.0020.0320.0180.0040.0380.0680.069
Income Tax Expense 36.3621.2566.8239.117.819.8713.1624.9125.917.18720.82733.8123.511.75217.30229.67328.59422.84211.7738.4755.05-0.355.7095.0725.0097.62444.4251.8180.608-0.456-0.9130-7.18429.6411.261.6033.5771.3731.591.67-1.360.0663.330.3082.8480.90.05-2.4644.73.31.56.5078.5237.3
Net Income 107.9565.83319.9114.5953.2935.4939.6374.7274.7956.02277.85104.1233.6930.2554.06573.07468.48150.98954.30340.08825.20315.54822.83220.29120.03729.74617.44317.6997.273-12.295-22.47-38.534-42.2078.15899.0425.0336.41420.0113.4914.3854.6550.6790.2623.6727.09812.228.8920.0590.0363.28710.844.1940.0069.40323.22325.401
Net Income Ratio 0.1430.1120.4320.1530.0870.0820.0840.1290.1240.1010.1290.1720.00600.0990.1230.1140.1190.0950.0710.080.0530.0540.0490.0440.0770.0420.040.017-0.038-0.059-0.133-0.1570.0280.2880.0130.0160.0510.010.0130.0130.0020.0010.0110.0210.0390.024000.0090.0220.0100.0230.050.053
EPS 1.60.984.741.722.011.311.512.852.852.142.973.970.140.012.022.512.611.942.071.530.960.590.870.770.761.140.670.680.28-0.47-0.86-1.47-1.610.313.780.190.240.760.130.170.180.0250.010.140.270.470.340.0020.0010.130.410.1600.360.890.97
EPS Diluted 1.580.984.741.71.931.311.472.852.852.142.973.970.140.012.022.512.611.942.071.530.960.590.870.770.761.140.670.680.28-0.47-0.86-1.47-1.610.313.780.190.240.760.130.170.180.0250.010.140.270.470.340.0020.0010.130.410.1600.360.890.97
EBITDA 170.3884.418413.4179.3983.9751.5659.17106.39106.3479.96103.746140.2299.2739.03475.649105.658100.96377.75870.17552.47734.30719.83932.14829.51629.08442.91424.79126.59713.339-11.008-20.449-37.343-37.6975.604137.92422.2824.54749.26823.75325.36125.57215.49118.70524.90729.26837.69529.33118.91120.49518.09735.05326.37619.60233.32749.60549.278
EBITDA Ratio 0.2250.1440.5580.240.1370.1190.1250.1840.1770.1440.1730.2320.0150.0170.1390.1780.1680.1820.1230.0930.1080.0670.0770.0710.0640.1120.0590.060.031-0.034-0.054-0.129-0.140.0190.4010.0560.0610.1260.0690.0760.0690.040.0580.0760.0860.1210.0780.0510.0540.0470.0710.0630.0530.080.1060.103